This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Novo Nordisk A/S (NVO)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 2.35B 2.03B 0.00 2.34B
Receivables 2.86B 2.81B 2.41B 2.20B
Inventories 1.85B 1.77B 1.69B 1.65B
Other Current Assets 45.88M 281.52M 165.01M 8.38M
Total Current Assets 7.56B 7.78B 7.12B 6.91B
Property, Plant & Equipment, Gross 7.75B 8.15B 7.55B 7.04B
Accumulated Depreciation & Depletion 3.98B 4.10B 3.73B 3.39B
Property, Plant & Equipment, Net 3.78B 4.05B 3.82B 3.65B
Intangibles 224.99M 298.92M 264.97M 259.88M
Other Non-Current Assets 139.76M 101.98M 40.41M 47.65M
Total Non-Current Assets 5.02B 5.23B 4.52B 4.38B
Liabilities & Shareholder Equity
Total Assets 12.58B 13.02B 11.64B 11.29B
Accounts Payable 1.62B 757.39M 683.97M 574.39M
Short Term Debt 117.55M 39.79M 88.62M 61.26M
Other Current Liabilities 3.02B 3.69B 3.06B 2.99B
Total Current Liabilities 5.50B 4.48B 3.84B 3.63B
Long Term Debt 0.00 0.00 0.00 87.62M
Deferred Income Taxes 1.14M 124.38M 129.74M 559.55M
Other Non-Current Liabilities 501.57M 531.39M 472.70M 482.23M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 502.71M 655.77M 602.44M 1.13B
Total Liabilities 6.00B 5.14B 4.44B 4.76B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 6.58B 7.88B 7.20B 6.54B
Common Par 86.53M 101.80M 99.25M 101.23M
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 6.74B 7.61B 6.91B 6.48B
Treasury Stock -1.80M -3.89M -3.01M -4.19M
Other Equity Adjustments -245.23M 167.14M 192.84M -38.22M
Total Capitalization 6.58B 7.88B 7.20B 6.62B
Total Equity 6.58B 7.88B 7.20B 6.54B
Total Liabilities & Stock Equity 12.58B 13.02B 11.64B 11.29B
Total Common Shares Outstanding 2.65B 2.75B 2.37B 2.47B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 57.00M 0.00 425.00M 0.00
Basic Weighted Shares Outstanding 2.62B 2.68B 2.74B 2.83B
Diluted Weighted Shares Outstanding 2.63B 2.69B 2.76B 2.85B
Number of Employees NA NA 34286 32000
Number of Part-Time Employees NA NA 0 0
NVO News

NVO Novo Nordisk A/S

Chart of NVO

Analysts Ratings for NVO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 2 2 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

NVO Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs